Management of Severe Opioid-Induced Pruritus in RLS Patient on Oxycodone
For severe opioid-induced itching in your RLS patient on oxycodone 20mg, first-line treatment is naltrexone (a μ-opioid receptor antagonist), with methylnaltrexone as an alternative if cessation of opioid therapy is not possible. 1
Stepwise Treatment Algorithm
First-Line: Opioid Antagonists
- Naltrexone is the most effective treatment for opioid-induced pruritus with strength of recommendation B 1
- Methylnaltrexone serves as an alternative μ-opioid antagonist with reduced blood-brain barrier penetration, minimizing risk of reversing analgesia 1
- Critical caveat: Careful dose titration is essential to avoid reversing analgesic efficacy or precipitating pain 2, 3
Second-Line Options (if antagonists fail or are contraindicated)
Consider these alternatives in order 1:
- Ondansetron 4-8 mg (5-HT3 receptor antagonist) - may reduce severity though evidence is mixed
- Mirtazapine 30 mg daily - proven effective in RCTs for morphine-induced pruritus
- Gabapentin 1200 mg daily in divided doses - dual benefit as it's also first-line for RLS 4
- Droperidol (parenteral, 2.5-5 mg IV) - for severe cases
Third-Line: Antihistamines (Limited Efficacy)
- Diphenhydramine or promethazine (sedating) 2, 3
- Cetirizine (non-sedating) 3
- Note: Antihistamines are generally less effective for opioid-induced pruritus compared to other causes of itching
Critical Decision Point: Opioid Rotation
If symptomatic management fails, strongly consider opioid rotation 2, 3. This is particularly important because:
- Different opioids have varying propensities to cause pruritus
- One case report demonstrated resolution of intractable morphine-induced pruritus after switching to oxycodone 5, though your patient is already on oxycodone
- Consider rotation to methadone or buprenorphine, which may have lower pruritus rates and are commonly used for RLS 4, 6
Special Consideration for RLS Context
Your patient presents a unique challenge requiring dual consideration:
The 2025 AASM RLS guidelines suggest extended-release oxycodone and other opioids for RLS treatment (conditional recommendation, moderate certainty) 4. However, they note that gabapentin is a strong first-line recommendation for RLS 4.
Optimal strategy: Add gabapentin 300-1200 mg daily (titrated) which addresses both:
This allows potential opioid dose reduction, which may decrease pruritus while maintaining RLS control.
Practical Implementation
- Immediate relief: Start naltrexone at low dose (3-6 mg) with careful monitoring for pain breakthrough 1
- Concurrent addition: Initiate gabapentin 300 mg at bedtime, titrate to 900-1200 mg divided doses over 1-2 weeks 4
- Monitor closely: Assess both pruritus severity and RLS symptom control at 1-2 week intervals
- Consider opioid taper: As gabapentin reaches therapeutic levels, attempt gradual opioid dose reduction by 25-50% every 2-4 days if RLS remains controlled 7
Common Pitfalls to Avoid
- Don't rely solely on antihistamines - they have poor efficacy for opioid-induced pruritus despite being commonly prescribed 2, 3
- Don't abruptly stop oxycodone - taper gradually to avoid withdrawal and RLS symptom rebound 7
- Don't use excessive naltrexone doses - higher doses (6-9 mg) risk reducing analgesia duration 1
- Don't ignore iron status - check ferritin and transferrin saturation, as iron supplementation is recommended for RLS when appropriate 4
The combination of naltrexone for immediate pruritus relief plus gabapentin for long-term RLS management with potential opioid-sparing effects represents the most evidence-based approach for this clinical scenario.